It is expected that the cataract surgery devices market will grow from USD 9.25 billion in 2025 to USD 12.47 billion by 2033, growing at a CAGR of 3.80% during the forecast period of 2025-2033. An increased incidence among aging populations, improved technologies for better surgery tools, and increased awareness regarding early treatment and restoration of vision are some factors that have triggered more adoptions of modern cataract surgeries across the world.
Cataract surgery devices include phacoemulsification systems, femtosecond lasers, and ophthalmic viscosurgical devices; they are specialized medical instruments and equipment that serve to remove clouded natural lenses from the eye and replace them with artificial intraocular lenses to restore clear vision. Advanced cataract surgery technologies make procedures minimally invasive, highly precise, and quicker, while offering faster recovery times and better visual outcomes. Modern IOLs, like multifocal, toric, and accommodating lenses, also correct refractive errors, reducing dependence on glasses after surgery.
Globally, there has been an increase in demand for cataract surgery devices, as the prevalence of cataracts-a worldwide cause of blindness-continues to rise, most especially among aging populations. Improved safety in surgery and better access and reimbursement policies have also widened adoption. Innovation such as laser-assisted surgery and digital imaging integration keeps improving success rates and will attract those seeking premium correction of vision. Attributed to increasing awareness about preventable blindness, expanding healthcare infrastructure, and growing demand for high-quality ophthalmic care, the market related to cataract surgery devices is showing sustained growth across the globe.
Headquarters: Switzerland
Alcon Inc (Alcon) develops and manufactures devices in the field of ophthalmology. The company's portfolio comprises contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various conditions that include cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate its products for safety and efficacy in order to prevent and cure blindness and different eye diseases. Alcon's pipeline products are developed through collaboration with institutions, medical innovators, research advisors and academic thought leaders. The company operates in the Americas, Europe, the Middle East, and Africa and Asia Pacific.
Headquarters: United States of America
Johnson & Johnson (J&J) is a US-based health care company involved in the research, development, manufacturing, and marketing of innovative medicines and medical technologies. The company conducts business through its operating companies. It provides pharmaceutical products for therapy areas related to immune disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; and medical devices for use in cardiovascular, orthopedic, neurovascular care, general surgery, and vision care fields. The company offers its products to retailers, wholesalers, healthcare professionals, and hospitals. It operates manufacturing units in the US, Europe, Asia-Pacific, Africa, Western Hemisphere (excluding the US), and Latin America.
Headquarters: Germany
Carl Zeiss AG (Carl Zeiss), a subsidiary of Carl Zeiss Stiftung AG, is a medical technology company that is engaged in manufacturing and commercialization of optical and optoelectronic products. The company's product portfolio encompasses lithography optics, microscopes, measuring technology, photomask systems, medical technology products including ophthalmic diagnostic and therapeutic products, eyeglass lenses, camera and cine lenses and binoculars. It also offers planetarium software for smaller, medium and large projection equipment for use in sky theaters, star theaters, and universe theaters. It serves a wide range of sectors including semiconductor, automotive and mechanical engineering, biomedical research and medical technology. The company has operations in EMEA, Americas, and APAC regions.
Headquarters: United States of America
Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Bausch Health Companies Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as conjunctivitis, glaucoma, eye allergies, dry eye and retinal diseases. It has presence across the Americas, Europe, the Middle East, Africa and Asia-Pacific.
Headquarters: Japan
Topcon Corp (Topcon) manufactures and distributes eye care products, positioning and smart infrastructure solutions. It provides eye care products comprising three-dimensional (3D) optical coherence tomography system, ophthalmic digital image filing, tonometer, specular microscope, auto refracto/kerato meter, chart projector, vision tester, lensmeter/analyzer, operation microscope, and laser photocoagulator. The company’s portfolio also includes GNSS receivers, IT site management solutions, machine control systems, 3D scanners, data collectors, digital level products, pipe laser, theodolite, mobile control systems, total stations and rotating lasers. The company also focuses on R&D and has research facilities across the US, Finland, Russia, Italy, Japan and Australia. The company sells its products through a network of distributors across the world.
It also commands immense strengths in cataract surgery devices on account of its leading position in vision correction technologies, strong brand equity, and expertise in the innovation of lenses. The company remains highly recognized for its premium intraocular lenses, which it designs to restore vision subsequent to cataract surgery, while concurrently correcting refractive errors such as astigmatism and presbyopia. With strong research capabilities and investment in next-generation materials and optical design, the company advances the outcomes of surgery and ensures increased patient satisfaction. Its global reach and strategic partnerships with eye care professionals and hospitals further enable broad market access for the company. Given the legacy that Essilor has built in eye health, and a robust product pipeline focused on customized visual solutions, it is well-placed to capture the growing demand for premium cataract correction options, including premium and multifocal intraocular lenses.
Cataract surgery devices include phacoemulsification systems, femtosecond lasers, and ophthalmic viscosurgical devices; they are specialized medical instruments and equipment that serve to remove clouded natural lenses from the eye and replace them with artificial intraocular lenses to restore clear vision. Advanced cataract surgery technologies make procedures minimally invasive, highly precise, and quicker, while offering faster recovery times and better visual outcomes. Modern IOLs, like multifocal, toric, and accommodating lenses, also correct refractive errors, reducing dependence on glasses after surgery.
Globally, there has been an increase in demand for cataract surgery devices, as the prevalence of cataracts-a worldwide cause of blindness-continues to rise, most especially among aging populations. Improved safety in surgery and better access and reimbursement policies have also widened adoption. Innovation such as laser-assisted surgery and digital imaging integration keeps improving success rates and will attract those seeking premium correction of vision. Attributed to increasing awareness about preventable blindness, expanding healthcare infrastructure, and growing demand for high-quality ophthalmic care, the market related to cataract surgery devices is showing sustained growth across the globe.
Top Manufacturers
Alcon AG
Establishment: 1945Headquarters: Switzerland
Alcon Inc (Alcon) develops and manufactures devices in the field of ophthalmology. The company's portfolio comprises contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various conditions that include cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate its products for safety and efficacy in order to prevent and cure blindness and different eye diseases. Alcon's pipeline products are developed through collaboration with institutions, medical innovators, research advisors and academic thought leaders. The company operates in the Americas, Europe, the Middle East, and Africa and Asia Pacific.
Johnson & Johnson Services Inc.
Establishment: 1886Headquarters: United States of America
Johnson & Johnson (J&J) is a US-based health care company involved in the research, development, manufacturing, and marketing of innovative medicines and medical technologies. The company conducts business through its operating companies. It provides pharmaceutical products for therapy areas related to immune disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; and medical devices for use in cardiovascular, orthopedic, neurovascular care, general surgery, and vision care fields. The company offers its products to retailers, wholesalers, healthcare professionals, and hospitals. It operates manufacturing units in the US, Europe, Asia-Pacific, Africa, Western Hemisphere (excluding the US), and Latin America.
Carl Zeiss Meditec AG
Establishment: 1846Headquarters: Germany
Carl Zeiss AG (Carl Zeiss), a subsidiary of Carl Zeiss Stiftung AG, is a medical technology company that is engaged in manufacturing and commercialization of optical and optoelectronic products. The company's product portfolio encompasses lithography optics, microscopes, measuring technology, photomask systems, medical technology products including ophthalmic diagnostic and therapeutic products, eyeglass lenses, camera and cine lenses and binoculars. It also offers planetarium software for smaller, medium and large projection equipment for use in sky theaters, star theaters, and universe theaters. It serves a wide range of sectors including semiconductor, automotive and mechanical engineering, biomedical research and medical technology. The company has operations in EMEA, Americas, and APAC regions.
Bausch & Lomb, Inc.
Establishment: 1853Headquarters: United States of America
Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Bausch Health Companies Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as conjunctivitis, glaucoma, eye allergies, dry eye and retinal diseases. It has presence across the Americas, Europe, the Middle East, Africa and Asia-Pacific.
Topcon Corp
Establishment: 1932Headquarters: Japan
Topcon Corp (Topcon) manufactures and distributes eye care products, positioning and smart infrastructure solutions. It provides eye care products comprising three-dimensional (3D) optical coherence tomography system, ophthalmic digital image filing, tonometer, specular microscope, auto refracto/kerato meter, chart projector, vision tester, lensmeter/analyzer, operation microscope, and laser photocoagulator. The company’s portfolio also includes GNSS receivers, IT site management solutions, machine control systems, 3D scanners, data collectors, digital level products, pipe laser, theodolite, mobile control systems, total stations and rotating lasers. The company also focuses on R&D and has research facilities across the US, Finland, Russia, Italy, Japan and Australia. The company sells its products through a network of distributors across the world.
Product Launches in the Cataract Surgery Devices Market
STAAR Surgical Co.
STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced the first implants of the EVO Visian® Implantable Collamer® lens (EVO ICL) in the U.S. The Company also announced its program of meetings and presentations during the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Washington, D.C., April 2022.Glaukos Corp
October 2025 - Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD / Epioxa™ (“Epioxa”) New Drug Application (NDA). Epioxa is a groundbreaking advance in corneal cross-linking for the treatment of keratoconus, a rare, sight-threatening disease that is currently far too often undiagnosed and untreated.SWOT Analysis of the Company
NIDEK Co., Ltd.
Strengths include: technological competence, precision engineering, and diversified ophthalmic product range.
With technological know-how, precision engineering, and a broad ophthalmic product portfolio, NIDEK Co., Ltd. addresses all major needs in the cataract surgery devices market. Recognized for its high-performance diagnostic and surgical equipment manufacturing, the company has established itself with phacoemulsification systems, optical biometers, and advanced imaging solutions. NIDEK’s reputation for accuracy, reliability, and user-friendly software enhances adoption among ophthalmologists and surgical centers worldwide. Its global distribution network and strong after-sales support further strengthen customer confidence. The company’s commitment to research and development drives continuous development in laser-assisted surgery, digital visualization, and minimally invasive cataract procedures. NIDEK is at the center of changing cataract care with hardware and software integrations that improve clinical and surgical outcomes, workflow efficiency, and the patient experience. These strengths place it as the trusted global provider in this fast-evolving ecosystem of cataract care.Essilor International S.A.
Strengths: Frontrunner status in vision correction technologies, strong brand presence, and expertise in lens innovationIt also commands immense strengths in cataract surgery devices on account of its leading position in vision correction technologies, strong brand equity, and expertise in the innovation of lenses. The company remains highly recognized for its premium intraocular lenses, which it designs to restore vision subsequent to cataract surgery, while concurrently correcting refractive errors such as astigmatism and presbyopia. With strong research capabilities and investment in next-generation materials and optical design, the company advances the outcomes of surgery and ensures increased patient satisfaction. Its global reach and strategic partnerships with eye care professionals and hospitals further enable broad market access for the company. Given the legacy that Essilor has built in eye health, and a robust product pipeline focused on customized visual solutions, it is well-placed to capture the growing demand for premium cataract correction options, including premium and multifocal intraocular lenses.
Recent Developments in the Cataract Surgery Devices Market
Abbott Laboratories
Nov. 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will allow it to enter and lead in fast-growing cancer diagnostics segments serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will be entitled to receive $105 per common share, representing a total equity value of approximately $21 billion. The combined companies will accelerate innovation, expand access to life-changing diagnostics, and help more people detect and manage cancer at its earliest, most treatable stages.Hoya Corporation
June 2025, HOYA Vision Care announced that it acquired Centennial Optical, a Canadian distributor. Centennial Optical has supplied ophthalmic frames, eyeglass lenses, sunglasses, lab supplies, and optical accessories. HOYA Vision Care is present today in more than 50 countries and is considered a leader in myopia management and has expertise in new, advanced lens design, high-performance photochromic technologies, and high-quality AR coatings. HOYA's acquisition of Centennial Optical better positions both companies for continued service to the Canadian market through additional resources and technologies that HOYA maintains, complemented by the foundation built by Centennial Optical.Sustainability Goal
Aurolab
Aurolab integrates sustainability into the manufacture of cataract surgery technology through the prioritization of affordability, ethical production, and environmental responsibility. The company focuses on the development of cost-effective intraocular lenses and ophthalmic consumables in an attempt to increase access to cataract surgery globally, especially in low- and middle-income settings. Aurolab works actively to reduce waste through streamlined manufacturing processes, recyclable packaging, and energy-optimized facilities. Its social sustainability efforts also involve collaborations with eye care NGOs and programs around the world that support its work for the prevention of blindness. At Aurolab, product development is aligned with humanitarian impact and environmental stewardship, promoting sustainable access to eye care at scale.HumanOptics AG
HumanOptics AG advances sustainability within the market for cataract surgery through environmentally conscious design, resource-efficient production, and high-quality implantable lenses for long-term use. It minimizes waste through precision-based manufacturing and strict material optimization. HumanOptics investigates further the application of bio-compatible and robust materials that decrease the need for postoperative replacements, enhancing long-term clinical sustainability. Energy-efficient programs and adherence to environmental standards allow facilities to reduce carbon emissions. HumanOptics also advocates for ethical clinical research and responsible sourcing. By innovation and alignment with sustainability imperatives, the company propels high-performance solutions in cataract management with minimal environmental footprints.Market Segmentation
Cataract Surgery Devices Market
- Historical Trends
- Forecast Analysis
Market Share Analysis - Cataract Surgery Devices Market
Alcon, Inc.
- Overview
- Company History and Mission
- Business Model and Operations
- Workforce
Key Persons
- Executive Leadership
- Operational Management
- Division Leaders
- Board Composition
Recent Development & Strategies
- Mergers & Acquisitions
- Partnerships
- Investments
Sustainability Analysis
- Renewable Energy Adoption
- Energy-Efficient Infrastructure
- Use of Sustainable Packaging Materials
- Water Usage and Conservation Strategies
- Waste Management and Circular Economy Initiatives
Product Analysis
- Product Profile
- Quality Standards
- Product Pipeline
- Product Benchmarking
Strategic Assessment: SWOT Analysis
- Strengths
- Weaknesses
- Opportunities
- Threats
Revenue Analysis
The above information will be available for all the following companies:
- Alcon, Inc.
- Johnson & Johnson
- Carl Zeiss Meditec AG
- Bausch & Lomb, Inc.
- Topcon Corp
- STAAR Surgical Co
- Glaukos Corp
- Abbott Laboratories
- Hoya Corporation
- NIDEK Co., Ltd.
- Essilor International S.A.
- Ziemer Ophthalmic Systems AG
- Oertli Instrumente AG
- Aurolab
- HumanOptics AG
- Rayner Group
- Santen Pharmaceutical Co., Ltd.
- Lumenis Be Ltd.
- Valeant Pharmaceuticals International (now Bausch+Lomb)
- AcuFocus, Inc.
Table of Contents
1. Cataract Surgery Devices Market
3. Alcon, Inc.
The above information will be provided for all the following companies:
Companies Mentioned
- Alcon, Inc.
- Johnson & Johnson
- Carl Zeiss Meditec AG
- Bausch & Lomb, Inc.
- Topcon Corp
- STAAR Surgical Co
- Glaukos Corp
- Abbott Laboratories
- Hoya Corporation
- NIDEK Co., Ltd.
- Essilor International S.A.
- Ziemer Ophthalmic Systems AG
- Oertli Instrumente AG
- Aurolab
- HumanOptics AG
- Rayner Group
- Santen Pharmaceutical Co., Ltd.
- Lumenis Be Ltd.
- Valeant Pharmaceuticals International (now Bausch+Lomb)
- AcuFocus, Inc.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 9.25 Billion |
| Forecasted Market Value ( USD | $ 12.47 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
